Scarica l'app Stockscreener
1.305
0.38%
-0.005
Dopo l'orario di chiusura:
1.29
-0.015
-1.15%
Precedente Chiudi:
$1.31
Aprire:
$1.31
Volume 24 ore:
3.05M
Relative Volume:
1.66
Capitalizzazione di mercato:
$485.80M
Reddito:
$106.34M
Utile/perdita netta:
$-74.66M
Rapporto P/E:
-1.3737
EPS:
-0.95
Flusso di cassa netto:
$-46.12M
1 W Prestazione:
-10.62%
1M Prestazione:
-19.94%
6M Prestazione:
-19.44%
1 anno Prestazione:
-45.40%
Intervallo 1D:
$1.1725
$1.31
Intervallo di 1 settimana:
$1.1725
$1.56
Portata 52W:
$1.1725
$3.04
Standard Biotools Inc Stock (LAB) Company Profile
Nome
Standard Biotools Inc
Settore
Industria
Telefono
(650) 266-6000
Indirizzo
2 TOWER PLACE, SOUTH SAN FRANCISCO
Confronta LAB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LAB
Standard Biotools Inc
|
1.305 | 485.80M | 106.34M | -74.66M | -46.12M | -0.95 |
|
ABT
Abbott Laboratories
|
131.44 | 227.98B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.98 | 156.20B | 16.75B | 1.85B | 1.89B | 1.25 |
|
SYK
Stryker Corp
|
390.48 | 148.86B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
91.20 | 116.94B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
70.91 | 41.82B | 6.60B | 4.16B | 490.10M | 6.93 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-04-16 | Iniziato | TD Cowen | Buy |
| 2024-04-04 | Iniziato | Jefferies | Buy |
| 2023-07-12 | Iniziato | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc Borsa (LAB) Ultime notizie
Fluidigm stock hits 52-week low at $1.21 amid market challenges - MSN
Standard BioTools Inc (LAB)’s Day in Review: Closing at 1.38, Down by -2.82 - The Dwinnex
Is Standard BioTools (NASDAQ:LAB) Using Debt Sensibly? - Simply Wall St
Standard BioTools Inc (NASDAQ: LAB): Can A Stock Be -21.71% Lower Year-To-Date And Still Be A Loser? - Marketing Sentinel
LAB’s 52-Week Rollercoaster: From $1.21 to $3.04 – What’s Next for Investors? - The InvestChronicle
Standard BioTools Inc [LAB] Records 200-Day SMA of $1.9928 - Knox Daily
SG Americas Securities LLC Acquires 34,670 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
LAB’s latest rating updates from top analysts. - Knox Daily
Investing in Standard BioTools Inc (LAB) might be a great opportunity, but the stock is a bit undervalued - US Post News
Financial Metrics Unveiled: Standard BioTools Inc (LAB)’s Key Ratios in the Spotlight - The Dwinnex
Fluidigm Corporation : SINGuLAR™ Analysis Toolset 2.1 -January 29, 2014 at 06:22 pm EST - Marketscreener.com
Sequencing Reagents Market Trends Analysis Report 2025-2030, with Illumina, QIAGEN, BGI, PacBio, Oxford Nanopore Technologies, Agilent Technologies, Standard BioTools, Takara Bio & Meridian Bioscience - Yahoo Finance
Standard BioTools (NASDAQ:LAB) Stock Price Down 5.8%What's Next? - MarketBeat
Standard BioTools Inc. (NASDAQ:LAB) Shares Purchased by JPMorgan Chase & Co. - Defense World
Genomics Market to Grow by USD 5.21 Billion (2024-2028), Boosted by Rising Investments in R&D, with AI Impacting Market TrendsTechnavio - Yahoo Finance
Genomics Market to Grow by USD 5.21 Billion (2024-2028), Boosted by Rising Investments in R&D, with AI Driving Market TransformationTechnavio - Yahoo Finance
Standard BioTools (NASDAQ:LAB) Stock Price Down 8.5%Should You Sell? - MarketBeat
Things To Consider Before You Buy Standard BioTools Inc (NASDAQ: LAB) - Stocks Register
Standard BioTools (NASDAQ:LAB) Shares Gap DownHere's Why - MarketBeat
Appian, Bitfarms, Standard BioTools, and More Stocks See Action From Activist Investors - MSN
Now Is The Time To Build A Position In Standard BioTools Inc (NASDAQ:LAB) - Marketing Sentinel
Standard BioTools (NASDAQ:LAB) Trading Down 5.8%Here's What Happened - MarketBeat
Standard BioTools stock soars on Q4 revenue beat By Investing.com - Investing.com South Africa
Standard BioTools stock soars on Q4 revenue beat - Investing.com India
Standard BioTools (NASDAQ:LAB) Shares Gap UpWhat's Next? - MarketBeat
Standard BioTools stock soars on upbeat preliminary 4Q revenue By Investing.com - Investing.com Canada
Intra-Cellular Therapies, Standard BioTools, SI-BONE And Other Big Stocks Moving Higher On Monday - Benzinga
Standard BioTools Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year 2024 - Marketscreener.com
Standard BioTools Reports 2024 Revenue Achievements and Plans - TipRanks
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2024 Revenue - The Manila Times
In the wake of Standard BioTools Inc.'s (NASDAQ:LAB) latest US$52m market cap drop, institutional owners may be forced to take severe actions - Simply Wall St
Standard BioTools Hits Top-End Revenue Target of $174M, Slashes Operating Costs in 2024 - StockTitan
Illumina launches pilot proteomics program with UK Biobank and biopharma collaborators to analyze 50,000 samples - PR Newswire
Standard BioTools announces CCO Jeremy Davis's departure By Investing.com - Investing.com Canada
Standard BioTools announces CCO Jeremy Davis's departure - Investing.com India
Standard BioTools Announces CCO Jeremy Davis’s Departure - TipRanks
Jane Street Group LLC Sells 60,340 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools SomaScan Assay Powers Key Insights into Semaglutide Treatment Published in Nature Medicine - The Manila Times
Principal Financial Group Inc. Has $43,000 Stock Position in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools' SomaScan Platform Breakthrough: Nature Medicine Study Reveals Semaglutide Insights - StockTitan
In the wake of Standard BioTools Inc.'s (NASDAQ:LAB) latest US$56m market cap drop, institutional owners may be forced to take severe actions - Yahoo Finance
Geode Capital Management LLC Buys 154,848 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools (NASDAQ:LAB) Stock Price Down 6.3%Should You Sell? - MarketBeat
Standard BioTools Inc. (NASDAQ:LAB) Shares Acquired by State Street Corp - MarketBeat
State Street Corp Purchases 1,157,984 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools Inc. (NASDAQ:LAB) Position Decreased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Barclays PLC Purchases 377,195 Shares of Standard BioTools Inc. (NASDAQ:LAB) - MarketBeat
Standard BioTools to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
Standard BioTools CEO to Present at J.P. Morgan Healthcare Conference 2024 - StockTitan
Standard BioTools (NASDAQ:LAB) Trading Down 6.8%Here's What Happened - MarketBeat
Standard Biotools Inc Azioni (LAB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.38%
1.34%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):